Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

Authors

Sawa Ito
Catherine M. Bollard, George Washington UniversityFollow
Mattias Carlsten
Jan Joseph MelenhorstFollow
Angélique Biancotto
Ena Wang
Jinguo Chen
Yuri Kotliarov
Foo Cheung
Zhi Xie
Francesco Marincola
Kazushi Tanimoto
Minoo Battiwalla
Matthew J. Olnes
Shira Perl
Paula Schum
Thomas E. Hughes
Keyvan Keyvanfar
Nancy Hensel
Pawel Muranski
Neal S. Young
A. John Barrett

Document Type

Journal Article

Publication Date

7-1-2014

Journal

Molecular therapy

Volume

Volume 22, Issue 7

Issue

7

Keywords

Interleukin-2--Pharmacology; T-Lymphocytes, Regulatory--Drug Effects

APA Citation

Ito, S., Bollard, C.M., Carlsten, M., Melenhorst J.J., Biancotto A., Wang, E., Chen, J., Kotliarov, Y., Cheung, F., Xie, Z., Marincola, F., Tanimoto, K., Battiwalla, M., Olnes, M.J., Perl, S., Schum, P., Hughes, T.E., Keyvanfar, K., Hensel, N., Muranski, P., Young, N.S., Barrett, A.J.

Peer Reviewed

1